COVID-19 disease has been in our lives for about 2 years. This frightening epidemic still kills thousands of people every day. Moreover, while the effects of the epidemic have only begun to decrease, the newly emerged Omicron variant also raises concerns about the epidemic, causing people to be even more afraid. That’s why experts in places like the World Health Organization (WHO) state that getting vaccinated is still the best way to protect against the virus.
Now, the World Health Organization has announced that it has approved another COVID-19 vaccine with a new statement. According to the statements, the vaccine produced in India against the new type of coronavirus and called Covavax was given an ’emergency use approval’. This approval made Covavax the ninth vaccine to be approved by the WHO.
Covavax becomes ninth vaccine approved
In the statements made by the World Health Organization today, the vaccine named Covovax, also known as NVX-CoV2373, which is produced by the Indian Serum Institute under the license of the US pharmaceutical company ‘Novavax’, announced that it has been approved for emergency use. In addition, it was emphasized that more people should be vaccinated and that efforts to vaccinate low-income countries should be increased.
WHO Deputy Director-General Dr. In her statements regarding this approval decision, Mariangela Simao said, “Although new variants such as Omicron continue to emerge, it would not be wrong to say that vaccines are still the most effective weapon against severe diseases and deaths from COVID-19. Our primary goal will be to send this approved vaccine to low-income countries with a vaccination rate of around 10%. Vaccination of people in these countries is of great importance for the course of the epidemic.
In addition, with this decision, the number of vaccines approved by WHO has increased to 9. The Geneva-based organization first approved the Pfizer/BioNTech vaccine in December 2020. Apart from this, AstraZeneca has also approved vaccines such as Moderna, Jannsen, Sinopharm and Sinovac. In addition, WHO announced at the beginning of last November that it had given emergency use approval for an Indian vaccine called Covaxin.
44840
